Skip to contentSkip to footer
A woman in a white lab coat examines a sample through a microscope in a laboratory, with shelves of colourful items in the background.

Become a Royal Marsden Pioneer  

Sign up to a monthly donation and help more people get tomorrow’s cancer treatments, today.Your support for The Royal Marsden Cancer Charity could help fund pioneering research that will lead to new life-saving treatments for patients, across the UK and around the world. 

Your monthly gift could save more lives 

The Royal Marsden is renowned for leading and pioneering the research behind life-saving treatments for people with cancer everywhere. With one in two of us likely to receive a diagnosis in our lifetime, cancer touches every family, generation and community, which is why we need new research breakthroughs more than ever before. 

For every £1 we raise 73p is made available for The Royal Marsden’s groundbreaking work.*

You don't have to develop a new cancer treatment to be a Royal Marsden Pioneer, simply set up a monthly donation today. You will receive a free keyring as a token of our thanks.

“My children were 5 and 7 when I received the news that I had just months to live. Now I’ve been able to see them go to college, which is amazing.” 

Lucy, 49, was diagnosed with stage three melanoma in 2011. She had surgery to remove the cancer and surrounding lymph nodes, but two years later, she received the devastating news that her disease had progressed, and she had just months to live.  

Thankfully, Lucy was referred to The Royal Marsden where she joined the international Checkmate 067 trial and received life-saving treatment. The trial involved taking a combination of immunotherapy drugs – ipilimumab and nivolumab. Thanks to this trial, in which Professor Larkin and his team at The Royal Marsden played a leading role, these drugs have since been approved and made available on the NHS, offering hope to thousands of melanoma patients.  

Lucy is now on a different treatment but says “I wouldn’t be here without the combination immunotherapy treatment I received, it saved my life.”  

Cancer rates are set to rise by 40% by 2050. Source: JAMA Oncology estimates a 41.7% rise in very high–HDI countries and IARC/WHO data show a 37% increase in the UK.

*2024/25 annual report

Header image photographer: Kirsten Holt

Become a Royal Marsden Pioneer and help support life-saving research